Related Experiment Video

Updated: Jun 22, 2026

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
11:21

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal

Published on: January 26, 2019

Apoptosis in cancer: key molecular signaling pathways and therapy targets

Claudia Burz1, Ioana Berindan-Neagoe, Ovidiu Balacescu

  • 1University of Medicine and Pharmacy I Hatieganu, Cluj-Napoca, Romania. cburz@yahoo.fr

Acta Oncologica (Stockholm, Sweden)
|June 11, 2009
PubMed

Insights

Apoptosis, a programmed cell death process, is crucial for development and homeostasis but also implicated in cancer. Understanding its pathways and resistance mechanisms is key for cancer treatment strategies.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Apoptosis is a fundamental physiological process essential for multicellular organism development and homeostasis.
  • Dysregulation of apoptosis is implicated in various pathological conditions, notably cancer.
  • Two primary mammalian apoptosis pathways exist: the extrinsic (receptor-mediated) and intrinsic (mitochondrial) pathways.

Purpose of the Study:

  • To review the molecular mechanisms and protein interactions governing apoptosis.
  • To explore the pathways contributing to apoptosis resistance.
  • To discuss the therapeutic modulation of apoptosis for cancer treatment.

Main Methods:

  • Literature review of scientific references on apoptosis.
  • Analysis of molecular pathways and protein interactions.
  • Examination of apoptosis resistance mechanisms.

Main Results:

  • Identification of key apoptotic molecules and their interactions.
  • Elucidation of mechanisms underlying resistance to programmed cell death.
  • Overview of strategies for modulating apoptosis in cancer therapy.

Conclusions:

  • While many apoptotic proteins are known, the complete molecular pathways of cellular death require further investigation.
  • Understanding apoptosis and its resistance is critical for developing effective cancer therapies.
  • Targeting apoptosis pathways offers a promising avenue for novel cancer treatments.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis12:55

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis

Published on: February 16, 2015

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...